Thymosin alpha-1 is a synthetic version of a naturally occurring peptide produced by the thymus gland. It plays a crucial role in modulating the immune system by stimulating the production of various immune cells, including T cells, B cells, and natural killer cells. In pharmaceutical chemistry, thymosin alpha-1 is studied for its potential therapeutic applications in boosting immune function and treating immune-related disorders, such as infections, cancer, and autoimmune diseases. It acts by enhancing the body’s defense mechanisms against pathogens and promoting the elimination of abnormal cells. Additionally, thymosin alpha-1 has shown promise in improving vaccine efficacy and reducing the severity of viral infections, including hepatitis B and C, HIV, and influenza. Its mechanism of action in regulating immune responses makes thymosin alpha-1 a valuable candidate for developing treatments in immunology and infectious diseases.
| CAS Number | 62304-98-7 |
| Synonyms | Zadaxin |
| Molecular Formula | C129H215N33O55 |
| Purity | 98 |
